Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Teak Jun Shin

Showing results (11-20 of 14) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 14 results.
Investigative and Clinical Urology|July 6, 2026
Risk of second primary cancer after radiotherapy for localized prostate cancer: A single-center Korean cohort studySung Hyun Bae, Hye Jin Byun, Hyeon Chan Jang, et al.
Journal of Surgical Oncology|October 13, 2020
Metastatic renal cell carcinoma to the pancreas: Clinical features and treatment outcomeTeak Jun Shin, Cheryn Song, Chang Wook Jeong, et al.
Prostate International|March 13, 2023
Current treatment patterns within 1 year after prostate cancer diagnosis in Korean patients over 75 years old: a retrospective multicenter studyDong Jin Park, Ho Won Kang, Se Yun Kwon, et al.
Prostate International|July 7, 2025
A randomized, active-controlled, multicenter, phase 3 clinical trial to evaluate the efficacy and safety of GV1001 in patients with benign prostatic hyperplasiaTeak Jun Shin, Ji Yong Ha, Se Yun Kwon, et al.
Pageof 2

Showing results (11-20 of 14) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 14 results.
Investigative and Clinical Urology|July 6, 2026
Risk of second primary cancer after radiotherapy for localized prostate cancer: A single-center Korean cohort studySung Hyun Bae, Hye Jin Byun, Hyeon Chan Jang, et al.
Journal of Surgical Oncology|October 13, 2020
Metastatic renal cell carcinoma to the pancreas: Clinical features and treatment outcomeTeak Jun Shin, Cheryn Song, Chang Wook Jeong, et al.
Prostate International|March 13, 2023
Current treatment patterns within 1 year after prostate cancer diagnosis in Korean patients over 75 years old: a retrospective multicenter studyDong Jin Park, Ho Won Kang, Se Yun Kwon, et al.
Prostate International|July 7, 2025
A randomized, active-controlled, multicenter, phase 3 clinical trial to evaluate the efficacy and safety of GV1001 in patients with benign prostatic hyperplasiaTeak Jun Shin, Ji Yong Ha, Se Yun Kwon, et al.
Pageof 2